Effects of tamoxifen and 4-hydroxytamoxifen on the pNR-1 and pNR-2 estrogen-regulated RNAs in human breast cancer cells.
Open Access
- 1 November 1987
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 262 (33), 15894-15899
- https://doi.org/10.1016/s0021-9258(18)47673-9
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- THE PREVENTION OF BREAST CANCERThe Lancet, 1986
- Tamoxifen stimulation of human breast cancer cell proliferation in vitro: a possible model for tamoxifen tumour flareEuropean Journal of Cancer and Clinical Oncology, 1984
- The pharmacology and clinical uses of tamoxifenPharmacology & Therapeutics, 1984
- The biology and physiology of ‘Nolvadex’ (tamoxifen) in the treatment of breast cancerBreast Cancer Research and Treatment, 1982
- Differences between oestrogen receptor activation by oestrogen and antioestrogenNature, 1981
- A secreted glycoprotein induced by estrogen in human breast cancer cell linesCell, 1980
- Purification of Mouse Immunoglobulin Heavy‐Chain Messenger RNAs from Total Myeloma Tumor RNAEuropean Journal of Biochemistry, 1980
- Establishment and characterization of a cell line of human breast carcinoma originEuropean Journal of Cancer (1965), 1979
- Detection of specific sequences among DNA fragments separated by gel electrophoresisJournal of Molecular Biology, 1975
- Oestrogen-responsive human breast cancer in long term tissue cultureNature, 1975